Search
for
Sort by
Research 811–840 of 1000+
- Endocrinology & Metabolism News, August 2005
- MiR-92a-1-5p and miR-328-3p Are Up-Regulated in Skin of Female Pattern Hair Loss Patients
- Menopause and Common Dermatoses: A Systematic Review
- Cutaneous changes in menopausal women: A cross-sectional study from a tertiary care center in south India
- 1375 Cutaneous adnexal cysts revisited: A novel classification based on morphological and molecular features
- 1371 FGF7-dependent inhibition of human hair growth byan osteopontin-derived peptide: A novel solution for hirsutism and hypertrichosis?
- Androgen treatment in women
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Tributyltin (TBT) effects on Ocinebrina aciculata (Gastropoda: Muricidae): imposex development, sterilization, sex change and population decline
- HAIR REGROWTH
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Androgens and androgen receptor action in skin and hair follicles
- Anti-androgenic activities of Ganoderma lucidum
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Cutaneous Side Effects of Oral Contraceptives
- Women's midlife health Reframing menopause
- Androgen antagonists in androgen target tissues
- Adverse health effects of androgen use
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Male hormonal contraception: looking back and moving forward
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Clinical use of 5α-reductase inhibitors
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- 4-O-Methylhonokiol: A lesser-known neolignan from Magnolia species with diverse and promising pharmacological properties
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?